|
Volumn 55, Issue 1, 2001, Pages 5-9
|
Verapamil SR and trandolapril combination therapy is safe and effective in hypertensive patients with metabolic disorders
a a a a
a
NONE
(Turkey)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBUMIN;
AMINOTRANSFERASE;
ANTIHYPERTENSIVE AGENT;
CHOLESTEROL;
CREATININE;
GLUCOSE;
HEMOGLOBIN A1C;
LOW DENSITY LIPOPROTEIN;
NITROGEN;
TRANDOLAPRIL;
TRIACYLGLYCEROL;
UREA;
VERAPAMIL;
ADULT;
ARTICLE;
BLOOD LEVEL;
COMORBIDITY;
CONTROLLED STUDY;
DIABETES MELLITUS;
DIASTOLIC BLOOD PRESSURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
FEMALE;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
HYPERTENSION;
KIDNEY FAILURE;
MAJOR CLINICAL STUDY;
MALE;
METABOLIC DISORDER;
MICROALBUMINURIA;
PRIORITY JOURNAL;
SLOW RELEASE FORMULATION;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
UREA NITROGEN BLOOD LEVEL;
ADULT;
ALBUMINURIA;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
DIABETES COMPLICATIONS;
DRUG COMBINATIONS;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
INDOLES;
KIDNEY FAILURE;
MALE;
METABOLIC DISEASES;
MIDDLE AGED;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
VERAPAMIL;
|
EID: 0035128881
PISSN: 13685031
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (15)
|